All Stories

  1. Patient perceptions and experiences with medication-related activities in the emergency department: a qualitative study
  2. Is anticholinergic and sedative drug burden associated with postdischarge institutionalization in community‐dwelling older patients acutely admitted to hospital? A Norwegian registry‐based study
  3. Self-reported medication information needs among medication users in a general population aged 40 years and above – the Tromsø study
  4. Community carriage of ESBL-producingEscherichia coliandKlebsiella pneumoniae: A cross-sectional study of risk factors and comparative genomics of carriage and clinical isolates
  5. Interdisciplinary collaboration across secondary and primary care to improve medication safety in the elderly (The IMMENSE study) – a randomized controlled trial
  6. Social network analysis of Staphylococcus aureus carriage in a general youth population
  7. Association of area-level education with the regional growth trajectories of rates of antibacterial dispensing to patients under 3 years in Norway: a longitudinal retrospective study
  8. Risk factors, immune response and whole‐genome sequencing of SARS‐CoV‐2 in a cruise ship outbreak in Norway
  9. Intervention fidelity and process outcomes of the IMMENSE study, a pharmacist‐led interdisciplinary intervention to improve medication safety in older hospitalized patients
  10. An introduction to network analysis for studies of medication use
  11. Integrating the clinical pharmacist into the emergency department interdisciplinary team: a study protocol for a multicentre trial applying a non-randomised stepped-wedge study design
  12. Antibacterial use by birth year and birth season in children 0-2 years in Norway
  13. Self-reported medication use among coronary heart disease patients showed high validity compared with dispensing data
  14. Gastrointestinal carriage of Klebsiella pneumoniae in a general adult population in Norway: a cross-sectional study of risk factors and bacterial genomic diversity
  15. Gastrointestinal carriage of Klebsiella pneumoniae in a general adult population: a cross-sectional study of risk factors and bacterial genomic diversity
  16. Empirical prescribing of penicillin G/V reduces risk of readmission of hospitalized patients with community-acquired pneumonia in Norway: a retrospective observational study
  17. The impact of hospitalisation to geriatric wards on the use of medications and potentially inappropriate medications - a health register study
  18. Wikipedia and Medicines: Who edits medicine articles on the English Wikipedia?
  19. Safety aspects of antiepileptic drugs—a population-based study of adverse effects relative to changes in utilisation
  20. Assessing Potentially Inappropriate Medications in Nursing Home Residents by NORGEP-NH Criteria
  21. Lower Cancer Incidence—Warfarin Effect or Immortal Time Bias?
  22. Reported time to onset of neurological adverse drug reactions among different age and gender groups using metoclopramide: an analysis of the global database Vigibase®.
  23. Adverse drug reaction reporting: how can drug consumption information add to analyses using spontaneous reports?
  24. Pain sensitivity and analgesic use among 10,486 adults: the Tromsø study
  25. Persistent analgesic use and the association with chronic pain and other risk factors in the population—a longitudinal study from the Tromsø Study and the Norwegian Prescription Database
  26. Persistent opioid use and socio-economic factors: a population-based study in Norway
  27. Concomitant medication among persistent opioid users with chronic non-malignant pain
  28. Laxative prescriptions to cancer outpatients receiving opioids: a study from the Norwegian prescription database
  29. The Morphine Manifesto
  30. Analgetika med refusjon ved kroniske smerter
  31. Differential patterns of opioid use: Defining persistent opioid use in a prescription database
  32. Choosing the unit of measurement counts: The use of oral morphine equivalents in studies of opioid consumption is a useful addition to defined daily doses
  33. How are opioids used in Norway? Persistent use, utilization of depot formulation and age profile in non-palliation patients
  34. Factors associated with success of market authorisation applications for pharmaceutical drugs submitted to the European Medicines Agency
  35. Unique Orbital Symmetry-Driven Cisoid Tilting of the Axial Ligands in Dialkylruthenium(IV) Porphyrins †